- Open
- 4.90
- High
- 5.20
- Low
- 5.05
- Close
- 5.20
- Change
- +0.10 (2.04%)
- Volume
- 350,565
⌘K
| 1 May 2026 | 12:00:01 | Partial Disposal of Shares in SkinBioTherapeutics |
| 1 Apr 2026 | 07:00:05 | Trading Update |
| 24 Feb 2026 | 07:00:10 | WellBiome® clinical trial on surgical outcomes |
| 17 Feb 2026 | 07:00:05 | Statement: SkinBioTherapeutics Announcement |
| 21 Jan 2026 | 07:00:07 | Large Order and Record Early Orders for 2026 |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 14 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
OptiBiotix Health is a biotech firm that focuses on cutting-edge research and development. Our primary focus is on preventing and treating chronic lifestyle diseases such as obesity, high cholesterol, lipid profiles, and diabetes.
| 1 May 2026 | 12:00:01 | Partial Disposal of Shares in SkinBioTherapeutics |
| 1 Apr 2026 | 07:00:05 | Trading Update |
| 24 Feb 2026 | 07:00:10 | WellBiome® clinical trial on surgical outcomes |
| 17 Feb 2026 | 07:00:05 | Statement: SkinBioTherapeutics Announcement |
| 21 Jan 2026 | 07:00:07 | Large Order and Record Early Orders for 2026 |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 14 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
OptiBiotix Health is a biotech firm that focuses on cutting-edge research and development. Our primary focus is on preventing and treating chronic lifestyle diseases such as obesity, high cholesterol, lipid profiles, and diabetes.